$CTIC Company News Insider filings one way to tr
Post# of 44845
Posted On: 02/27/2014 1:00:06 PM
$CTIC Company News
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com
Cell Therapeutics' Pixuvri gets final NICE recommendation 9:47 a.m. Today - Seeking Alpha
Interesting CTIC Put And Call Options For April 19th 11:01 a.m. Feb. 26, 2014 - TheStreet.com
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule 7:33 a.m. Feb. 26, 2014 - TheStreet.com
TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer 5:18 p.m. Jan. 31, 2014 - Seeking Alpha
Biotech Stock Mailbag: Cell Therapeutics and the Ariad Hostile React-o-Meter Meltdown 6:00 a.m. Jan. 31, 2014 - TheStreet.com
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
First Week Of CTIC January 2016 Options Trading 1:18 p.m. Jan. 22, 2014 - TheStreet.com
Cell Therapeutics (CTIC) Highlighted As Today's Perilous Reversal Stock 9:46 a.m. Jan. 22, 2014 - TheStreet.com
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013 7:00 a.m. Jan. 21, 2014 - TheStreet.com
Five Worst, Pandering Drug Stocks of J.P. Morgan Healthcare Confab Week 3:52 p.m. Jan. 17, 2014 - TheStreet.com
Cell Therapeutics provides corporate update, share rise 8:25 a.m. Jan. 14, 2014 - Seeking Alpha
Cell Therapeutics Regains Rights to Two In-Development Cancer Medicines 4:47 p.m. Jan. 13, 2014 - Wall St. Cheat Sheet
The J.P. Morgan Healthcare Confab Monday Morning News Dump 9:06 a.m. Jan. 13, 2014 - TheStreet.com
Cell Therapeutics regains rights to cancer compounds from Novartis 8:23 a.m. Jan. 13, 2014 - Seeking Alpha
Cell Therapeutics to Reacquire Rights to Two Anti-Cancer Compounds from Novartis 5:01 a.m. Jan. 13, 2014 - benzinga.com
Time to Analyze Small-Caps Again 1:00 p.m. Jan. 10, 2014 - RealMoney.com
Cell Therapeutics Inc. (CTIC) Shares March Higher, Can It Continue? - Tale of the Tape 7:47 a.m. Jan. 7, 2014 - Zacks.com
BAX Recalls Parenteral Nutrition Injections - Analyst Blog 7:15 p.m. Jan. 6, 2014 - Zacks.com
Is Cell Therapeutics Turning Over A New Leaf In 2014? 11:35 a.m. Jan. 6, 2014 - Seeking Alpha
Cell Therapeutics rallies on NICE nod for Pixuvri 9:02 a.m. Jan. 6, 2014 - Seeking Alpha
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 1:30 a.m. Today - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 1:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 9:17 a.m. Feb. 24, 2014 - ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC) 10:11 a.m. Feb. 11, 2014 - ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors 1:30 a.m. Feb. 3, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia 1:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer 1:30 a.m. Jan. 28, 2014 - PR Newswire - PRF
Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC) 7:22 a.m. Jan. 20, 2014 - ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources 10:52 a.m. Jan. 14, 2014 - ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress 1:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds 1:30 a.m. Jan. 13, 2014 - PR Newswire - PRF
Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics 8:00 a.m. Jan. 7, 2014 - PR Newswire
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE 1:30 a.m. Jan. 6, 2014 - PR Newswire
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat 1:30 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement 1:30 a.m. Dec. 18, 2013 - PR Newswire
Positive Trend Scan List: Cell Therapeutics Inc, Micron Technology, Tiger Oil and Energy, General Motors, Twitter Inc 9:25 a.m. Dec. 10, 2013 - PR Newswire
Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting 1:30 a.m. Dec. 10, 2013 - PR Newswire
Integrated Safety and Efficacy Analysis of Phase 2 Clinical Trials of Pacritinib in Patients with Myelofibrosis and Low Platelet Counts Presented at ASH Annual Meeting 11:30 a.m. Dec. 9, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com
Cell Therapeutics' Pixuvri gets final NICE recommendation 9:47 a.m. Today - Seeking Alpha
Interesting CTIC Put And Call Options For April 19th 11:01 a.m. Feb. 26, 2014 - TheStreet.com
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule 7:33 a.m. Feb. 26, 2014 - TheStreet.com
TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer 5:18 p.m. Jan. 31, 2014 - Seeking Alpha
Biotech Stock Mailbag: Cell Therapeutics and the Ariad Hostile React-o-Meter Meltdown 6:00 a.m. Jan. 31, 2014 - TheStreet.com
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
First Week Of CTIC January 2016 Options Trading 1:18 p.m. Jan. 22, 2014 - TheStreet.com
Cell Therapeutics (CTIC) Highlighted As Today's Perilous Reversal Stock 9:46 a.m. Jan. 22, 2014 - TheStreet.com
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013 7:00 a.m. Jan. 21, 2014 - TheStreet.com
Five Worst, Pandering Drug Stocks of J.P. Morgan Healthcare Confab Week 3:52 p.m. Jan. 17, 2014 - TheStreet.com
Cell Therapeutics provides corporate update, share rise 8:25 a.m. Jan. 14, 2014 - Seeking Alpha
Cell Therapeutics Regains Rights to Two In-Development Cancer Medicines 4:47 p.m. Jan. 13, 2014 - Wall St. Cheat Sheet
The J.P. Morgan Healthcare Confab Monday Morning News Dump 9:06 a.m. Jan. 13, 2014 - TheStreet.com
Cell Therapeutics regains rights to cancer compounds from Novartis 8:23 a.m. Jan. 13, 2014 - Seeking Alpha
Cell Therapeutics to Reacquire Rights to Two Anti-Cancer Compounds from Novartis 5:01 a.m. Jan. 13, 2014 - benzinga.com
Time to Analyze Small-Caps Again 1:00 p.m. Jan. 10, 2014 - RealMoney.com
Cell Therapeutics Inc. (CTIC) Shares March Higher, Can It Continue? - Tale of the Tape 7:47 a.m. Jan. 7, 2014 - Zacks.com
BAX Recalls Parenteral Nutrition Injections - Analyst Blog 7:15 p.m. Jan. 6, 2014 - Zacks.com
Is Cell Therapeutics Turning Over A New Leaf In 2014? 11:35 a.m. Jan. 6, 2014 - Seeking Alpha
Cell Therapeutics rallies on NICE nod for Pixuvri 9:02 a.m. Jan. 6, 2014 - Seeking Alpha
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 1:30 a.m. Today - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 1:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 9:17 a.m. Feb. 24, 2014 - ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC) 10:11 a.m. Feb. 11, 2014 - ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors 1:30 a.m. Feb. 3, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia 1:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer 1:30 a.m. Jan. 28, 2014 - PR Newswire - PRF
Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC) 7:22 a.m. Jan. 20, 2014 - ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources 10:52 a.m. Jan. 14, 2014 - ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress 1:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds 1:30 a.m. Jan. 13, 2014 - PR Newswire - PRF
Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics 8:00 a.m. Jan. 7, 2014 - PR Newswire
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE 1:30 a.m. Jan. 6, 2014 - PR Newswire
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat 1:30 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement 1:30 a.m. Dec. 18, 2013 - PR Newswire
Positive Trend Scan List: Cell Therapeutics Inc, Micron Technology, Tiger Oil and Energy, General Motors, Twitter Inc 9:25 a.m. Dec. 10, 2013 - PR Newswire
Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting 1:30 a.m. Dec. 10, 2013 - PR Newswire
Integrated Safety and Efficacy Analysis of Phase 2 Clinical Trials of Pacritinib in Patients with Myelofibrosis and Low Platelet Counts Presented at ASH Annual Meeting 11:30 a.m. Dec. 9, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼